Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,750 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Yohimbine in erectile dysfunction: the facts.
Morales A. Morales A. Int J Impot Res. 2000 Mar;12 Suppl 1:S70-74. Int J Impot Res. 2000. PMID: 10845767 Review.
Yohimbine, a pharmacologically well-characterized alpha-2-adrenoceptor antagonist with activity in the central and peripheral nervous system, has been used for over a century in the treatment of erectile dysfunction. ...Despite such a long history and encoura …
Yohimbine, a pharmacologically well-characterized alpha-2-adrenoceptor antagonist with activity in the central and peripheral nervous …
TEMPE: Topical Eutectic-Like Mixture for Premature Ejaculation.
Henry R, Morales A, Wyllie MG. Henry R, et al. Among authors: morales a. Expert Opin Drug Deliv. 2008 Feb;5(2):251-61. doi: 10.1517/17425247.5.2.251. Expert Opin Drug Deliv. 2008. PMID: 18248322 Review.
OBJECTIVE: TEMPE (Topical Eutectic-Like Mixture for Premature Ejaculation; Plethora Solutions Plc.) is a proprietary metered-dose aerosol containing a combination of the well-known local anaesthetics lidocaine and prilocaine in a novel formulation. The author …
OBJECTIVE: TEMPE (Topical Eutectic-Like Mixture for Premature Ejaculation; Plethora Solutions Plc.) is a proprietary metered-dose aer …
Intralesional recombinant alpha-interferon for localized prostate cancer: a pilot study with follow-up of >10 years.
Emerson L, Morales A. Emerson L, et al. Among authors: morales a. BJU Int. 2009 Oct;104(8):1068-70. doi: 10.1111/j.1464-410X.2009.08482.x. Epub 2009 Mar 30. BJU Int. 2009. PMID: 19338545 Clinical Trial.
PATIENTS AND METHODS: Ten men with localized prostate cancer participated in a study involving the intraprostatic injection of IFN-alpha, weekly for 5 weeks. ...The last patient has a low (<4 ng/mL) PSA level, negative biopsies and had 'no cancer' in a res …
PATIENTS AND METHODS: Ten men with localized prostate cancer participated in a study involving the intraprostatic injection of IFN-al …
A review of the current status of topical treatments for premature ejaculation.
Morales A, Barada J, Wyllie MG. Morales A, et al. BJU Int. 2007 Sep;100(3):493-501. doi: 10.1111/j.1464-410X.2007.07051.x. Epub 2007 Jul 3. BJU Int. 2007. PMID: 17608824 Review.
Unlike the cream formulations, the TEMPE spray has a well-controlled delivery system, making it easy to administer locally, and it appears to be well tolerated in early clinical trials. It appears that topical treatments might be able to satisfy many of the requirements of …
Unlike the cream formulations, the TEMPE spray has a well-controlled delivery system, making it easy to administer locally, and it ap …
Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome.
McLaren D, Siemens DR, Izard J, Black A, Morales A. McLaren D, et al. Among authors: morales a. BJU Int. 2008 Nov;102(9):1142-6. doi: 10.1111/j.1464-410X.2008.07811.x. Epub 2008 Jun 6. BJU Int. 2008. PMID: 18540933
OBJECTIVE: To report on a clinical practice series of testosterone-replacement therapy (TRT) in men with testosterone deficiency syndrome (TDS), examining clinical efficacy, biochemical parameters and effects on prostate health over a 2-year period. PATIENTS AND MET …
OBJECTIVE: To report on a clinical practice series of testosterone-replacement therapy (TRT) in men with testosterone deficiency synd …
BCG: A throwback from the stone age of vaccines opened the path for bladder cancer immunotherapy.
Morales A. Morales A. Can J Urol. 2017 Jun;24(3):8788-8793. Can J Urol. 2017. PMID: 28646932 Review.
Despite its efficacy, a considerable number (30%-40%) of these tumors fail to respond to BCG. In addition, as a live bacterium it carries the potential for serious adverse effects and some patients are unable to tolerate it. ...The enduring use of immunotherapy for …
Despite its efficacy, a considerable number (30%-40%) of these tumors fail to respond to BCG. In addition, as a live bacterium …
Determining the role of testosterone deficiency in sexual function: the beginning of the end or the end of the beginning?
Morales A. Morales A. Eur Urol. 2014 Jan;65(1):113-4. doi: 10.1016/j.eururo.2013.09.028. Epub 2013 Sep 24. Eur Urol. 2014. PMID: 24079954 No abstract available.
A novel approach to premature ejaculation: extracorporeal functional magnetic stimulation.
Morales A, Black A, Clark-Pereira J, Emerson L. Morales A, et al. Can J Urol. 2009 Feb;16(1):4458-62. Can J Urol. 2009. PMID: 19222883
AIM: To investigate the effect of extracorporeal functional magnetic stimulation (FMS) as a noninvasive treatment for men with PE. ...Treatment involved a first phase of five biweekly sessions (primary outcome). Men who reported an improvement in IVELT and desired t …
AIM: To investigate the effect of extracorporeal functional magnetic stimulation (FMS) as a noninvasive treatment for men with PE. .. …
Endocrine aspects of sexual dysfunction in men.
Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Tan HM, Torres LO. Morales A, et al. J Sex Med. 2004 Jul;1(1):69-81. doi: 10.1111/j.1743-6109.2004.10111.x. J Sex Med. 2004. PMID: 16422986 Review.
The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five continents developed in a scientific and debate process. ...RESULTS: Hypogonadism is a clinical and biochemical syndrome char …
The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five …
Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A, Black AM, Emerson LE. Morales A, et al. BJU Int. 2009 Jan;103(1):62-4. doi: 10.1111/j.1464-410X.2008.07882.x. Epub 2008 Jul 29. BJU Int. 2009. PMID: 18671790
One of the five patients had a transitory increase in PSA level but none had levels of >1.5 ng/mL. All patients reported a marked response in the manifestations of TDS, i.e. four each reported decreased hot flushes, decreased fatigue and improved libido, and two …
One of the five patients had a transitory increase in PSA level but none had levels of >1.5 ng/mL. All patients reported a
1,750 results
Jump to page
Feedback